Coronary artery spasm A 2009 update

Circulation

Volumn 119, Issue 18, 2009, Pages 2531-2534

  Stern, Shlomo ^a,c   DeLuna, Antoni Bayes ^b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b UNIVERSITY OF BARCELONA   (Spain)

^c NONE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; ERGOMETRINE; GLYCERYL TRINITRATE; NITRIC OXIDE SYNTHASE; VASODILATOR AGENT;

ADULT; CASE REPORT; CIGARETTE SMOKING; CORONARY ARTERY SPASM; ELECTROCARDIOGRAPHY MONITORING; ENDOTHELIAL DYSFUNCTION; ETHNIC DIFFERENCE; FOLLOW UP; HEART INFARCTION; HEART PALPITATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; MALE; PRIORITY JOURNAL; REVIEW; ST SEGMENT ELEVATION; THORAX PAIN; PATHOPHYSIOLOGY; VARIANT ANGINA PECTORIS;

ADULT; ANGINA PECTORIS, VARIANT; CALCIUM CHANNEL BLOCKERS; CORONARY VASOSPASM; HUMANS; MALE; NITROGLYCERIN; VASODILATOR AGENTS;

EID: 66549117612     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.843474     Document Type: Review

References (24)

1. Onaka H, Hirota Y, Shimada S, Kita Y, Sakai Y, Kawakami Y, Suzuki S, Kawamura K. Clinical observation of spontaneous anginal attacks and multivessel spasm in variant angina pectoris with normal coronary arteries: evaluation by 24-hour 12-lead elec-trocardiography with computer analysis. J Am Coll Cardiol. 1996;27:38-44.
2. Cannon CP, Braunwald E. Unstable angina and non-ST elevation myocardial infarction. In: Libby P, Bonow RO, Mann DL, Zipes DP, eds, Braunwald's Heart Disease. 8th ed. Philadelphia, PA: Saunders Elsevier; 2008: 1319-1351.
3. Egashira K, Katsuda Y, Mohri M, Kuga T, Tagawa T, Shimokawa H, Takeshita. Basal release of endothelium-derived nitric oxide at site of spasm in patients with variant angina. J Am Coll Cardiol. 1996;27:1444-1449.
4. Nakano T, Osanai T, Yomita H, Sekimata M, Homma Y, Okumura K. Enhanced activity of variant phospholipase C-δ1 protein (R257H) detected in patients with coronary artery spasm. Circulation. 2002; 105:2024-2029.
5. Murase Y, Yamada Y, Hirashiki A, Ichihara S, Kanda H, Watarai M, Takatsu Murohara T, Yokota M. Genetic risk and gene-environment interaction in coronary artery spasm in Japanese men and women. Eur Heart J. 2004;25:970-977.
6. Suzuki S, Yoshimura M, Nakayama M, Abe K, Yamamuro M, Nagayoshi Y, Kojima S, Kaikita K, Sugiyama S, Yasue H, Ogawa H. A novel genetic marker for coronary spasm in women from a genome-wide single nucle-otide polymorphism analysis. Pharmacogenet Genomics. 2007;17:919-930.
7. Takaoka K. Comparison of the risk factors for coronary artery spasm with those for organic stenosis in a Japanese population: role of cigarette smoking. Int J Cardiol. 2000;72:121-126.
8. Pozzati A, Pancaldi LG, Di Pasquale G, Pinelli G, Bugiardini P. Transient sympa-thovagal imbalance triggers "ischemic" sudden death in patients undergoing electro-cardiographic Holter monitoring. J Am Coll Cardiol. 1996;27:847-852.
9. Teragawa H, Kato M, Yamagata T, Matsuura H, Kajiyama G. The preventive effect of magnesium on coronary spasm in patients with vasospastic angina. Chest. 2000;118:1690-1695.
10. Treasure CB, Klein JL, Weuntraub WS, Talley JD, Stillabower ME, Kosinski AS, Zhang J, Boccuzzi SJ, Cedarholm JC, Alexander RW. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med. 1995;332: 481-487.
11. Yasue H, Mizuno Y, Harada E, Itoh T, Nakagawa H, Nakayama M, Ogawa H, Tayama S, Honda T, Hokimoto S, Ohshima S, Hokamura Y, Kugiyama K, Horie M, Yoshimura M, Harada M, Uemura S, Saito Y, for the SCAST (Statin and Coronary Artery Spasm Trial) Investigators. Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, Fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers. J Am Coll Cardiol. 2008;51: 1742-1748.
12. Ono T, Ohashi T, Asakura T, Shin T. Internal mammary revascularization in patients with variant angina and normal coronary arteries. Interact Cardiovasc Thorac Surg. 2005;4:426-428.
13. Sueda S, Suzuki J, Watanabe K, Kondou T, Yano K, Ochi T, Ochi N, Kawada H, Hayashi Y, Uraoka T. Comparative results of coronary intervention in patients with variant angina versus those with non-variant angina. Jpn Heart J. 2001;42:657-667.
14. Al-Sayegh A, Shukkur AM, Akbar M. Automatic implantable cardioverter defibrillator for the treatment of ventricular fibrillation following coronary artery spasm: a case report. Angiology. 2007;58:122-125.
15. Gange C, Madias C, Felix-Getzik EM, Weintraub AR, Mark Estes NA III. Variant angina associated with bitter orange in a dietary supplement. Mayo Clin Proc. 2006; 81:545-548.
16. El Menyar AA. Drug-induced myocardial infarction secondary to coronary artery spasm in teenagers and young adults. J Postgrad Med. 2006;52:51-58.
17. Koshiba K, Hoka S. Clinical characteristics of perioperative coronary spasm: reviews of 115 case reports in Japan. J Anesth. 2001;15: 93-99.
18. Wong A, Cheng A, Chan C, Lim YL. Car-diogenic shock caused by severe coronary artery spasm immediately after stenting. Tex Heart Inst J. 2005;32:78-80.
19. John J, Kaye G. Coronary spasm as a cause of sudden death induced by malignant ventricular arrhythmia. Br J Cardiol. 2005;12: 231-234.
20. Pristipino C, Beltrame JF, Finocchiaro ML, Hattori R, Fujita M, Mongiardo R, Cianflone D, Sanna T, Sasayama S, Maseri A. Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation. 2000;101:1102-1108.
21. Sasayama S. Heart disease in Asia. Circulation. 2008:118:2669-2671.
22. Ong P, Athanasiadis A, Hill S, Vogelsberg H, Voehringer M, Sechtem U. Coronary artery spasm as a frequent cause of acute coronary syndrome: the CASPAR (Coronary Artery Spasm in Patients with Acute Coronary Syndrome) study. J Am Coll Cardiol. 2008;52:523-527.
23. Da Costa A, Isaaz K, Faure E, Mourot S, Cerisier A, Lamaud M. Clinical characteristics, aetiological factors and long-term prognosis of myocardial infarction with an absolutely normal coronary angiogram: a 3-year follow-up study of 91 patients. Eur Heart J. 2001:1459-1465.
24. Goto A, Ito S, Kondo H, Nomura Y, Yasue N, Suzumura H, Takeda Y, Tomimoto S, Itoh M. Evaluation of adjunctive intra-coronary administration of acetylcholine following intravenous infusion of ergonovine to provoke coronary artery spasm. J Cardiol. 1999;34:309-316.